Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 50 of 199

1.

A Computerized Prompt for Thromboprophylaxis in Hospitalized Cancer Patients.

Candelario GD, Francis CW, Panzer R, McAdam KS, Cockrell D, Baird T, Khorana AA.

Thromb Res. 2009 Oct 29. [Epub ahead of print] No abstract available. PMID: 19878976 [PubMed - as supplied by publisher]Related articles

2.

Impact of venous thromboembolism and anticoagulation on cancer and cancer survival.

Kuderer NM, Ortel TL, Francis CW.

J Clin Oncol. 2009 Oct 10;27(29):4902-11. Epub 2009 Sep 8. Review.PMID: 19738120 [PubMed - indexed for MEDLINE]Related articles

3.

Prevention of venous thromboembolism in hospitalized patients with cancer.

Francis CW.

J Clin Oncol. 2009 Oct 10;27(29):4874-80. Epub 2009 Aug 24. Review.PMID: 19704060 [PubMed - indexed for MEDLINE]Related articles

4.

Foxp3 regulates megakaryopoiesis and platelet function.

Bernard JJ, Seweryniak KE, Koniski AD, Spinelli SL, Blumberg N, Francis CW, Taubman MB, Palis J, Phipps RP.

Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1874-82. Epub 2009 Aug 6.PMID: 19661482 [PubMed - in process]Related articles

5.

Platelet proteome changes associated with diabetes and during platelet storage for transfusion.

Springer DL, Miller JH, Spinelli SL, Pasa-Tolic L, Purvine SO, Daly DS, Zangar RC, Jin S, Blumberg N, Francis CW, Taubman MB, Casey AE, Wittlin SD, Phipps RP.

J Proteome Res. 2009 May;8(5):2261-72.PMID: 19267493 [PubMed - indexed for MEDLINE]Related articles

6.

Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study.

Yao JL, Ryan CK, Francis CW, Kohli M, Taubman MB, Khorana AA.

Cancer Invest. 2009 May;27(4):430-4.PMID: 19219655 [PubMed - indexed for MEDLINE]Related articles

7.

The platelet as an immune cell-CD40 ligand and transfusion immunomodulation.

Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP.

Immunol Res. 2009 Jan 29. [Epub ahead of print]PMID: 19184537 [PubMed - as supplied by publisher]Related articles

8.

New issues in oral anticoagulants.

Francis CW.

Hematology Am Soc Hematol Educ Program. 2008:259-65.PMID: 19074093 [PubMed - indexed for MEDLINE]Related articlesFree article

9.

Warfarin: an historical perspective.

Francis CW.

Hematology Am Soc Hematol Educ Program. 2008:251. No abstract available. PMID: 19074091 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.

Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH.

Arch Intern Med. 2008 Nov 24;168(21):2377-81.PMID: 19029504 [PubMed - indexed for MEDLINE]Related articles

11.

15-deoxy-Delta12,14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis.

O'Brien JJ, Baglole CJ, Garcia-Bates TM, Blumberg N, Francis CW, Phipps RP.

J Thromb Haemost. 2009 Jan;7(1):182-9. Epub 2008 Oct 10.PMID: 18983509 [PubMed - indexed for MEDLINE]Related articles

12.

Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer.

Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J, Mackman N, Taubman MB.

J Thromb Haemost. 2008 Nov;6(11):1983-5. Epub 2008 Sep 15. No abstract available. PMID: 18795992 [PubMed - indexed for MEDLINE]Related articles

13.

15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes.

O'Brien JJ, Spinelli SL, Tober J, Blumberg N, Francis CW, Taubman MB, Palis J, Seweryniak KE, Gertz JM, Phipps RP.

Blood. 2008 Nov 15;112(10):4051-60. Epub 2008 Aug 28.PMID: 18755987 [PubMed - indexed for MEDLINE]Related articlesFree article

14.

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

RE-MOBILIZE Writing Committee, Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA.

J Arthroplasty. 2009 Jan;24(1):1-9. Epub 2008 Apr 14.PMID: 18534438 [PubMed - indexed for MEDLINE]Related articles

15.

The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.

Spinelli SL, O'Brien JJ, Bancos S, Lehmann GM, Springer DL, Blumberg N, Francis CW, Taubman MB, Phipps RP.

PPAR Res. 2008;2008:328172.PMID: 18288284 [PubMed - in process]Related articlesFree article

16.

Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles.

Ray DM, Spinelli SL, Pollock SJ, Murant TI, O'Brien JJ, Blumberg N, Francis CW, Taubman MB, Phipps RP.

Thromb Haemost. 2008 Jan;99(1):86-95.PMID: 18217139 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

Development and validation of a predictive model for chemotherapy-associated thrombosis.

Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW.

Blood. 2008 May 15;111(10):4902-7. Epub 2008 Jan 23.PMID: 18216292 [PubMed - indexed for MEDLINE]Related articlesFree article

18.

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW; American Society of Clinical Oncology.

J Clin Oncol. 2007 Dec 1;25(34):5490-505. Epub 2007 Oct 29. Review.PMID: 17968019 [PubMed - indexed for MEDLINE]Related articles

19.

Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2).

Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW.

J Thromb Haemost. 2008 Jan;6(1):176-83. Epub 2007 Oct 22.PMID: 17949478 [PubMed - indexed for MEDLINE]Related articles

20.

Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.

Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH.

Cancer. 2007 Nov 15;110(10):2339-46.PMID: 17918266 [PubMed - indexed for MEDLINE]Related articlesFree article

21.

A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.

Kuderer NM, Khorana AA, Lyman GH, Francis CW.

Cancer. 2007 Sep 1;110(5):1149-61. Review.PMID: 17634948 [PubMed - indexed for MEDLINE]Related articlesFree article

22.

Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer.

Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, Hostetter G, Harvey J, Taubman MB.

Clin Cancer Res. 2007 May 15;13(10):2870-5.PMID: 17504985 [PubMed - indexed for MEDLINE]Related articlesFree article

23.

Effects of pioglitazone on fasting and postprandial levels of lipid and hemostatic variables in overweight non-diabetic patients with coronary artery disease.

Mieszczanska H, Kaba NK, Francis CW, Gerich JE, Dodis R, Schwarz KQ, Phipps RP, Smith BH, Lee M, Messing S, Taubman MB.

J Thromb Haemost. 2007 May;5(5):942-9.PMID: 17461928 [PubMed - indexed for MEDLINE]Related articles

24.

Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients.

Francis CW.

N Engl J Med. 2007 Apr 5;356(14):1438-44. Review. No abstract available. Erratum in: N Engl J Med. 2007 Jul 12;357(2):203. PMID: 17409325 [PubMed - indexed for MEDLINE]Related articles

25.

Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy.

Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH.

J Thromb Haemost. 2007 Mar;5(3):632-4. No abstract available. PMID: 17319909 [PubMed - indexed for MEDLINE]Related articles

26.

The platelet as a therapeutic target for treating vascular diseases and the role of eicosanoid and synthetic PPARgamma ligands.

O'Brien JJ, Ray DM, Spinelli SL, Blumberg N, Taubman MB, Francis CW, Wittlin SD, Phipps RP.

Prostaglandins Other Lipid Mediat. 2007 Jan;82(1-4):68-76. Epub 2006 Jul 10. Review.PMID: 17164134 [PubMed - indexed for MEDLINE]Related articles

27.

Venous thromboembolism in patients with diffuse large B-cell lymphoma.

Komrokji RS, Uppal NP, Khorana AA, Lyman GH, Kaplan KL, Fisher RI, Francis CW.

Leuk Lymphoma. 2006 Jun;47(6):1029-33.PMID: 16840193 [PubMed - indexed for MEDLINE]Related articles

28.

Thromboembolism in hospitalized neutropenic cancer patients.

Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH.

J Clin Oncol. 2006 Jan 20;24(3):484-90.PMID: 16421425 [PubMed - indexed for MEDLINE]Related articles

29.

Direct thrombin inhibitors for treatment of heparin induced thrombocytopenia, deep vein thrombosis and atrial fibrillation.

Francis CW.

Curr Pharm Des. 2005;11(30):3931-41. Review.PMID: 16305522 [PubMed - indexed for MEDLINE]Related articles

30.

Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.

Khorana AA, Francis CW, Culakova E, Lyman GH.

Cancer. 2005 Dec 15;104(12):2822-9.PMID: 16284987 [PubMed - indexed for MEDLINE]Related articlesFree article

31.

Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.

Colwell CW Jr, Berkowitz SD, Lieberman JR, Comp PC, Ginsberg JS, Paiement G, McElhattan J, Roth AW, Francis CW; EXULT B Study Group.

J Bone Joint Surg Am. 2005 Oct;87(10):2169-77.PMID: 16203879 [PubMed - indexed for MEDLINE]Related articles

32.

FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis.

Sahni A, Khorana AA, Baggs RB, Peng H, Francis CW.

Blood. 2006 Jan 1;107(1):126-31. Epub 2005 Sep 13.PMID: 16160009 [PubMed - indexed for MEDLINE]Related articlesFree article

33.

Endothelial cell activation by IL-1beta in the presence of fibrinogen requires alphavbeta3.

Sahni A, Sahni SK, Francis CW.

Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2222-7. Epub 2005 Aug 25.PMID: 16123330 [PubMed - indexed for MEDLINE]Related articlesFree article

34.

Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction.

Moss AJ, Ryan D, Oakes D, Goldstein RE, Greenberg H, Bodenheimer MM, Brown MW, Case RB, Dwyer EM Jr, Eberly SW, Francis CW, Gillespie JA, Krone RJ, Lichstein E, MacCluer JW, Marcus FI, McCarthy J, Sparks CE, Zareba W.

Am J Cardiol. 2005 Jul 15;96(2):177-82.PMID: 16018837 [PubMed - indexed for MEDLINE]Related articles

35.

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS; THRIVE Treatment Study Investigators.

JAMA. 2005 Feb 9;293(6):681-9.PMID: 15701909 [PubMed - indexed for MEDLINE]Related articlesFree article

36.

Fibrinogen regulates the expression of inflammatory chemokines through NF-kappaB activation of endothelial cells.

Guo M, Sahni SK, Sahni A, Francis CW.

Thromb Haemost. 2004 Oct;92(4):858-66.PMID: 15467918 [PubMed - indexed for MEDLINE]Related articles

37.

Ultrasound energy improves myocardial perfusion in the presence of coronary occlusion.

Siegel RJ, Suchkova VN, Miyamoto T, Luo H, Baggs RB, Neuman Y, Horzewski M, Suorsa V, Kobal S, Thompson T, Echt D, Francis CW.

J Am Coll Cardiol. 2004 Oct 6;44(7):1454-8.PMID: 15464327 [PubMed - indexed for MEDLINE]Related articles

38.

Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells.

Sahni A, Sahni SK, Simpson-Haidaris PJ, Francis CW.

J Thromb Haemost. 2004 Sep;2(9):1629-36.PMID: 15333041 [PubMed - indexed for MEDLINE]Related articles

39.

Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires alphavbeta3.

Sahni A, Francis CW.

Blood. 2004 Dec 1;104(12):3635-41. Epub 2004 Aug 5.PMID: 15297314 [PubMed - indexed for MEDLINE]Related articlesFree article

40.

Ximelagatran: a new oral anticoagulant.

Francis CW.

Best Pract Res Clin Haematol. 2004 Mar;17(1):139-52. Review.PMID: 15171963 [PubMed - indexed for MEDLINE]Related articles

42.

Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes.

Akbiyik F, Ray DM, Gettings KF, Blumberg N, Francis CW, Phipps RP.

Blood. 2004 Sep 1;104(5):1361-8. Epub 2004 May 6.PMID: 15130939 [PubMed - indexed for MEDLINE]Related articlesFree article

43.

Low-intensity ultrasound increases endothelial cell nitric oxide synthase activity and nitric oxide synthesis.

Altland OD, Dalecki D, Suchkova VN, Francis CW.

J Thromb Haemost. 2004 Apr;2(4):637-43.PMID: 15102020 [PubMed - indexed for MEDLINE]Related articles

44.

Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction.

Kaba NK, Francis CW, Moss AJ, Zareba W, Oakes D, Knox KL, Fernández ID, Rainwater DL; THROMBO Investigators.

J Thromb Haemost. 2004 May;2(5):718-25.PMID: 15099276 [PubMed - indexed for MEDLINE]Related articles

45.

Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form.

Sahni A, Guo M, Sahni SK, Francis CW.

Blood. 2004 Jul 15;104(2):409-14. Epub 2004 Mar 23.PMID: 15039285 [PubMed - indexed for MEDLINE]Related articlesFree article

46.

Consultations on patients with venous or arterial diseases.

Alving BM, Francis CW, Hiatt WR, Jackson MR.

Hematology Am Soc Hematol Educ Program. 2003:540-58. Review.PMID: 14633798 [PubMed - indexed for MEDLINE]Related articlesFree article

47.

Identification of a binding site on human FGF-2 for fibrinogen.

Peng H, Sahni A, Fay P, Bellum S, Prudovsky I, Maciag T, Francis CW.

Blood. 2004 Mar 15;103(6):2114-20. Epub 2003 Nov 20.PMID: 14630795 [PubMed - indexed for MEDLINE]Related articlesFree article

48.

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW Jr; EXULT A Study Group.

N Engl J Med. 2003 Oct 30;349(18):1703-12.PMID: 14585938 [PubMed - indexed for MEDLINE]Related articlesFree article

49.

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW.

J Thromb Haemost. 2003 Oct;1(10):2119-30.PMID: 14521593 [PubMed - indexed for MEDLINE]Related articles

50.

Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight.

Khorana AA, Sahni A, Altland OD, Francis CW.

Arterioscler Thromb Vasc Biol. 2003 Nov 1;23(11):2110-5. Epub 2003 Aug 14.PMID: 12920044 [PubMed - indexed for MEDLINE]Related articlesFree article

Supplemental Content

Find related data

Search details

» See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

» See more...